GWM
DERM icon

Geneos Wealth Management’s Journey Medical DERM Stock Holding History

Geneos Wealth Management’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$448K Buy
+63,280
New +$361K 0.01% 764
2026
Q1 		– Sell
-63,280
Closed -$488K – 2494
2025
Q4 		$488K Hold
63,280
– – 0.01% 673
2025
Q3 		$451K Hold
63,280
– – 0.01% 681
2025
Q2 		$454K Hold
63,280
– – 0.01% 736
2025
Q1 		$373K Hold
63,280
– – 0.01% 717
2024
Q4 		$247K Hold
63,280
– – 0.01% 773
2024
Q3 		$358K Hold
63,280
– – 0.01% 628
2024
Q2 		$357K Buy
+63,280
New +$260K 0.02% 572

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Geneos Wealth Management's DERM Position: Q2 2026 in Review

Geneos Wealth Management opened a new position in Journey Medical (DERM) in Q2 2026: 63,280 shares worth $448K. The stake represents 0.01% of the portfolio and ranks #764 among its holdings. This is a return to the name: Geneos Wealth Management previously reported a position in DERM as recently as Q4 2025.

Geneos Wealth Management first reported a position in DERM in Q2 2024 and has held it in 8 quarters since. The position peaked at $488K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Geneos Wealth Management held 63,280 shares of Journey Medical worth $448K as of Q2 2026.
  • Journey Medical was a new Geneos Wealth Management position in Q2 2026.
  • Journey Medical made up 0.01% of Geneos Wealth Management's portfolio in Q2 2026, its #764 holding.
  • Geneos Wealth Management first reported a position in Journey Medical in Q2 2024 and has held it in 8 quarters since.
  • Geneos Wealth Management's Journey Medical position peaked at $488K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.